Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells

Song Zhang1, Cuilian Liu1, Xiaobo Zhang1

  • 1College of Life Sciences and Laboratory for Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology, Zhejiang University, Hangzhou 310058, People's Republic of China.

Insights

MicroRNA-1 (miR-1) destroys cancer stem cell mitochondria by targeting key genes and proteins. Upregulating miR-1 in cancer stem cells induces mitophagy, offering new insights into mitochondrial regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial respiration is crucial for cell survival.
  • The role of microRNAs (miRNAs) in regulating mitochondrial function remains underexplored.
  • Cancer stem cells exhibit distinct metabolic and mitochondrial properties.

Purpose of the Study:

  • To investigate the effect of microRNA-1 (miR-1) on cancer stem cell mitochondria.
  • To elucidate the molecular mechanisms by which miR-1 influences mitochondrial morphology and function.
  • To explore the potential of miR-1 as a therapeutic target in cancer stem cells.

Main Methods:

  • Quantitative real-time PCR to measure miR-1 expression in cancer stem cells and non-stem cells.
  • Overexpression of miR-1 in cancer cell lines.
  • Western blotting and immunofluorescence to assess protein levels and localization.
  • Luciferase reporter assays to confirm direct targeting of genes.
  • In vitro and in vivo assays to evaluate mitophagy and mitochondrial damage.

Main Results:

  • miR-1 was significantly downregulated in melanoma stem cells (MSCs) and breast cancer stem cells (BCSCs).
  • Overexpression of miR-1 in cancer stem cells led to mitochondrial destruction and mitophagy.
  • miR-1 directly targeted the 3' UTRs of MINOS1 and GPD2 genes and interacted with LRPPRC protein.
  • MINOS1, GPD2, and LRPPRC are essential for mitochondrial inner membrane integrity.
  • miR-1 overexpression did not induce mitochondrial damage in non-stem cancer cells.

Conclusions:

  • miR-1 plays a critical role in regulating mitochondrial morphology and function specifically in cancer stem cells.
  • The mechanism involves direct targeting of MINOS1, GPD2, and interaction with LRPPRC, leading to mitophagy.
  • These findings provide novel insights into miRNA-mediated mitochondrial regulation and suggest miR-1 as a potential therapeutic strategy against cancer stem cells.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K